Changes to IR35 legislation
The impending alterations to how pharma will engage with contractors may not be at the top of to do lists – but it should be, says Charlie Cox
Read More
Search Results for: Charlie Cox
- Cambridge researchers develop robotic nerve devices for neurological conditions
- International phase 3 clinical trial for new melanoma treatment recruits first patients
- Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD
- Study reveals vitamin D-altered mouse gut bacteria provides better cancer immunity
- Cambridge researchers use AI to accelerate drug design for Parkinson’s disease
